AM Edition
Premarket briefing for 2026-06-29
Released 2026-06-29 17:05 UTC. This version is kept as released.
Changed since 2026-06-28
| Newly exposed assets | ABBV, CMG, GS, JPM, MSFT, MUX, OBIO, SMH, TBPH, ZYME |
| No longer in focus | ACN, AGNC, BRK.B, COP, CRCL, D, NEE, NVDA, USO |
| New event types | None |
| # | Event | Type | Exposed |
|---|---|---|---|
| 1 | SpaceX Announces $60B Acquisition of AI Code Editor Cursor Sources: SpaceX's $60 Billion Cursor Acquisition Changes Everything (2026-06-29) | corporate | SPCX |
| 2 | SK Hynix to Raise $29B via Nasdaq Listing for Capacity Expansion Sources: SK Hynix Just Sent a Huge Warning to Micron Investors (2026-06-29) | corporate | MU |
| 3 | OpenAI Considers Delaying IPO to Target $1T Valuation Sources: OpenAI IPO: Everything You Need to Know (2026-06-29) | corporate | MSFT |
| 4 | VanEck Semiconductor ETF (SMH) Signals Potential Market Top Sources: VanEck Semiconductor ETF Is Flashing an Ominous Warning Sign (2026-06-29) | market structure | SMH |
| 5 | Jefferies Reports Record Investment Banking Revenue Amid Mixed Q2 Sources: Jefferies Reports Earnings Before the Big Banks (2026-06-28) | earnings | GS, JPM |
| 6 | SpaceX Internal Launch Subsidies Question Starlink Profitability Sources: How SpaceX Uses a Secret Launch Subsidy to Make Starlink Look Insanely Profitable (2026-06-29) | market structure | SPCX |
| 7 | Ford Pivots to Battery Energy Storage Systems (BESS) for AI Data Centers Sources: 1 Unstoppable Trend That Could Supercharge Ford Stock by 2030 (2026-06-28) | supply chain | F |
| 8 | Study Shows 16% of Patients Return to Humira After Biosimilar Switch Sources: New study examines real-world switching patterns after patients transition from Humira to biosimilars (2026-06-29) | regulation | ABBV |
| 9 | Chipotle Down 53% Since 50-for-1 Stock Split Sources: 3 Reasons Why Chipotle Is Down 53% Since Its 50-for-1 Stock Split (2026-06-29) | market structure | CMG |
| 10 | Zymeworks to Acquire Theravance Biopharma for $929 Million Sources: Zymeworks to Acquire Theravance Biopharma, Inc. (2026-06-29) | corporate | TBPH, ZYME |
| 11 | Russell Index Reconstitution Adds New Biotech and Mining Names Sources: Orchestra BioMed Joins Russell 3000® and Russell 2000® Indexes (2026-06-29) | market structure | OBIO, MUX |
Only items that passed source verification are listed. Event descriptions are summaries of the cited reporting, not investment advice.